This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Transgene S.a., National Institute of Health and Medical Research. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 159 
2 out of 1,853 
Years Active: 2010-2013
Title: Maria Dimitrova-Tchomakov: Innovator in Hepatitis C Research
Introduction
Maria Dimitrova-Tchomakov is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of medical research, particularly in the development of therapeutic applications for hepatitis C. With a total of 3 patents to her name, her work has the potential to impact the treatment of this viral infection.
Latest Patents
Maria's latest patents focus on a composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of the hepatitis C virus (HCV). These inventions relate to a peptidic compound that includes the polyprotein NS3/NS4 and the polypeptide NS5B of HCV. Additionally, her patents describe expression vectors, such as adenovirus and poxvirus, that contain nucleic sequences coding for these components. The inventive compounds she has developed can be utilized for therapeutic applications, showcasing her innovative approach to combating hepatitis C.
Career Highlights
Throughout her career, Maria has worked with notable organizations, including Transgene S.A. and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Anne Fournillier and Jean-Daniel Abraham. Their collaborative efforts have further advanced the research and development of therapeutic solutions for hepatitis C.
Conclusion
Maria Dimitrova-Tchomakov is a dedicated inventor whose work in hepatitis C research is paving the way for innovative therapeutic applications. Her contributions are vital to the ongoing fight against this viral infection, and her patents reflect her commitment to improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile